Biochemistry: molecular-cellular-lab-genetics-nutrition-metabolism Flashcards
Chromatin structure
- DNA exits int he condensed, chromatin from in order to fit into nucleus
- negatively charged DNA loops 2x around positively charged histone octamer to form nucleosome bead
- histones are rich in the amino acids lysine & arginine
- H1 ties nucleosome beads together in a string
- in mitosis, DNA condenses to form chromosomes.
Heterochromatin
- condensed, transcriptionally inactive, sterically inaccessible
- HeteroChromatin=Highly Condensed
Euchromatin
Less condensed, transcriptionally active, sterically accessible.
-Eu=true, truly transcribed
DNA methylation
-template strand Cytosine & Adenine are methylated in DNA replication, which allows mismatch repair enzymes to distinguish between old & new strands in prokaryotes
Histone methylation
inactivates transcription of DNA
-Methylation makes DNA Mute (M-M)
Histone acetylation
Relaxes DNA coiling, allowing for transcription
-Acetylation makes DNA Active (A_A)
Nucleotides
-PURines (A, G)-2 rings= “PUR As Gold”
-PYrimidines (CTU)- 1 ring= CUT the PY (pie)
-Guanine has a ketone. Thymine has a methyl. THYmine has a meTHYl
-Deamination of cytosine makes uracil.
-Uracil found in RNA; thymine in DNA
G-C bond (3 H bonds) stronger than A-T bond (2 H bond).
-increase G-C content= increase melting temperature
-GAG- amino acids necessary for purine synthesis
-Glycine
-Aspartate
-Glutamine
-nucleoSide=base + ribose (Sugar)
-nucleoTides=base + ribose + phosphaTe;
linked by 3’-5’ phosphodiester bond
De novo pyrimidine & purine synthesis
Purines:
-start with sugar + phosphate (PRPP)
-add base
Pyrimidines:
-make temporary base (orotic acid)
-add sugar + phosphate (PRPP)
-modify base
-ribonucleotides are synthesized first & are converted to deoxyribonucleotides by ribonucleotide reductase
-carbamoyl phosphate is involved in 2 metabolic pathways:
1. de novo pyrimidine synthesis & urea cycle
2. ornithine transcarbamoylase deficiency (OTC, key enzyme
in urea cycle).
-leads to accumulation of carbamoyl phosphate, which
is converted to orotic acid.
-various antineoplastic & antibiotic drugs function by interfering
with purine synthesis:
1. hydroxyurea inhibits ribonucleotide reductase
2. 6-mercaptopurine (6-MP) blocks de novo purine synthesis
3. 5-fluorouracil (5-FU) inhibits thymidylate synthase
(decrease deoxythymidine monophosphate [dTMP]
4. methotrexate (MTX) inhibits dihydrofolate reductase
(decrease dTMP)
5. trimethoprim (TMP) inhibits bacterial dihydrofolate reductase
(decrease dTMP)
- Orotic aciduria:
- finding:
- treatments:
Orotic aciduria:
-inability to convert orotic acid to UMP (de novo pyrimidine synthesis pathway) because of defect in UMP synthase (a bifunctional enzyme). -Autosomal recessive.
Finding:
-increase orotic acid in urine,
-megaloblastic anemia (does not improve with administration of vit B12 or folic acid),
failure to thrive
-no hyperammonemia (vs. OTC deficiency= increase orotic acid with hyperammonemia)
Treatments:
Purine Salvage Deficiencies:
-Adenosine deaminase deficiency
- excess ATP & dATP imbalances nucleotide pool via feedback inhibition of ribonucleotide reductase—> prevents DNA synthesis & thus decrease lymphocyte count.
- one of major causes of SCID
- autosomal recessive
- Severe Combined Immunodeficiency Disease (SCID) happens to KIDS
- 1 st disease to be treated by experimental human gene therapy
Purine Salvage Deficiencies:
-Lesch-Nyhan syndrome
-defective purine salvage owing to absence of HGPRT, which converts:
hypoxanthine–> IMP &
guanine—> GMP
-result in excess uric acid production & de novo purine synthesis
-x-linked recessive
Findings:
- retardation
- self-mutilation
- aggression
- hyperuricemia
- gout
- choreoathetosis
Genetic Code Features:
- unambiguous:
- degenerate/redundant:
- commaless, nonoverlapping
- universal
- unambiguous:
each codon specifies only one amino acid - degenerate/redundant:
-most amino acids are coded by multiple codons
-exceptions: methione & tryptophan encoded by only 1 codon (AUG & UGG) - commaless, nonoverlapping
-read from fixed starting point as a continuous sequence of bases
-except some viruses - universal
-genetic code is conserved throughout evolution
-except in humans–> mitochondria
Genetic Code Features:
- unambiguous:
- degenerate/redundant:
- commaless, nonoverlapping
- universal
- unambiguous:
each codon specifies only one amino acid - degenerate/redundant:
-most amino acids are coded by multiple codons
-exceptions: methione & tryptophan encoded by only 1 codon (AUG & UGG) - commaless, nonoverlapping
-read from fixed starting point as a continuous sequence of bases
-except some viruses - universal
-genetic code is conserved throughout evolution
-except in humans–> mitochondria
Point mutations in DNA
- silent:
- missense:
- nonsense:
- frameshift:
- severity less–>greatest
- silent:
- same amino acid, often base change in 3rd position of codon (tRNA wobble) - missense:
- changed amino acid (conservative-new amino acid is similar in chemical structure) - nonsense:
- change resulting in early stop codon
- “Stop the nonsense” - frameshift:
- misreading of all nucleotides downstream
- truncated, nonfunctional pattern - silent<frameshift
- DNA Replication
- origin of replication
- replication fork
- helicase
- single-stranded binding proteins
- DNA topoisomerases
- primase
- DNA polymerase III
- DNA polymerase I
- DNA ligase
- Telomerase
- DNA Replication
- Eukaryotic DNA replication is more complex than the prokaryotic process but uses many enzymes.
- both prokaryotes & eukaryotes=DNA replication is semiconservative & involves both continuous & discontinuous (Okazaki fragment) synthesis - origin of replication
- particular consensus sequence of base pairs in genome where DNA replication begins.
- may be single (prokaryotes) or multiple in eukaryotes - replication fork
- Y-shaped region along DNA template where leading & lagging strands are synthesized - helicase
- unwinds DNA template at replication fork - single-stranded binding proteins
- prevent strands from reannealing - DNA topoisomerases
- create nick in helix relieve supercoils created in replication
- fluoroquinolones= inhibit DNA gyrase (prokaryotic topoisomerase II) - primase
- makes RNA primer on which DNA polymerase III can initiate replication - DNA polymerase III
- prokaryotes only
- elongates leading strand adding deoxynucleotides to the 3’ end.
- elongates lagging strand until it reaches primer of preceding fragment
- 3’-5’ exonuclease activity “proofreads” each added nucleotide
- DNA pol III has 5’-3’ synthesis & proofreads with 3’-5’ exonuclease - DNA polymerase I
- prokaryotes only
- degrades RNA primer
- replaces it with DNA
- has same functions as DNA polymerase III but also excises RNA primer with 5’-3’ exonuclease - DNA ligase
- catalyzes formation of phosphodiesterase bond within a strand of double stranded DNA (Okazki frag)
- seals - Telomerase
- enzyme adds DNA to 3’ end chromosomes to avoid loss genetic material with every duplication
DNA repair Single strand 1. nucleotide excision repair 2. base excision repair 3. mismatch repair
Single strand
- nucleotide excision repair
- specific endonucleases release the oligonucleotide-containing damaged bases
- DNA polymerase & ligase fill and reseal the gap.
- repairs bulky helix distorting leions
- mutated in xeroderma pigmentosum, which prevents repair of pyrimidine dimers because of ultraviolet light exposure - base excision repair
- specific glycosylases recognize and remove damaged bases, apurinic/apyrimidinic endonuclease cuts DNA at both apurinic and apyrimidinic sites
- empty sugar is removed
- gap is filled and resealed
- important in repair of spontaneous/toxic deamination - mismatch repair
- newly synthesized strand is recognized
- mismatched nucleotides are removed
- gap filled and resealed
- mutated in hereditary nonpolyposis colorectal cancer (HNPCC)
DNA repair
Double strand
1. nonhomologous end joining
- nonhomologous end joining
- brings together 2 ends of DNA fragments to repair double stranded breaks.
- no requirement for homology
- mutated in ataxia telangiectasia
DNA/RNA/Protein synthesis direction
-DNA & RNA synthesized 5’-3’
(5’ of incoming nucleotide bears triphosphate energy source for bond)
-triphosphate bond is target of 3’ hydroxyl attack.
-drugs blocking DNA replication often have modified 3’OH, preventing addition of next nucleotide–>chain termination
-mRNA read 5’-3’
-protein synthesis is N-terminus to C-terminus
Types of RNA
- rRNA-most abundant type
- mRNA longest type
- tRNA smallest type
rampant, massive, tiny
Start & stop codons
- mRNA start
a. euk
b. prok - mRNA stop
- AUG or rarely GUG (AUG in AUGurates protein synthesis)
a.) codes for methionine, may be removed before translation is completed
b.) codes for formylmethionine (f-met) - UGA= U Go Away
UAA= U Are Away
UAG= U Are Gone
Regulation of gene expression
- promoter
- enhancer
- silencer
- promoter
- site where RNA pol and multiple other transcription factors bind to DNA upstream from gene locus (AT rich upstream sequence with TATA and CAAT)
- promoter mutation commonly results in dramatic decrease in amount of gene transcribed - enhancer
- stretch of DNA that alters gene expression by binding transcription factors
- enhancers and silencers may be located close to, far from, or even within (in an intron) the gene whose expression it regulates - silencer
- site where negative regulators (repressors) bind
RNA pol
- Euk
- Prok
- Euk
- RNA pol I: makes rRNA (most numerous RNA, rampant)
- RNA pol II: makes mRNA (largest RNA massive
- RNA pol III: makes tRNA (smallest RNA, tiny)
- no proofreading function but initiate chains. RNA pol II opens DNA at promoter site
- pol I, II, III, numbered as their products are used in protein synthesis
- alpha-amanitin in Amanita phalloides (death cap mushrooms), inhibits RNA polymerase II.Causes severe hepatotoxicity if ingested - Prok
- 1 RNA pol (multisubunit complex) makes all 3 kinds of RNA
RNA processing (Euk)
- initial transcript is called heterogeneous nuclear RNA (hnRNA), hnRNA destined for translation is called pre-mRNA
- only processed RNA is transported out of nucleus
- processing occurs in nucleus
- after transcription:
1. capping 5’ end (addition of 7-methylguanosine cap)
2. polyadenylation on 3’ end (=200 A’s)
3. splicing out of introns - Poly A polymerase does not require a template AAUAAA=polyadenylation signal
- capped, tailed, spliced transcript=mRNA
Splicing of pre-MRNA
3 steps
- primary transcript combines with snRNPs and other proteins to form spliceosome.
- Lariat-shaped (looped) intermediate is generated.
- lariat is released to remove intron precisely and join 2 exons
* *patients with lupus make antibodies to spliceosomal snRNPs.
Intron vs. Exons
- exons contain the actual genetic info coding for protein
- introns are intervening noncoding segments of DNA
- INtrons are INtervening sequences and say IN the nucleus, whereas EXons EXit and are EXpressed.
- different exons can be combined by alternative splicing to make unique proteins in different tissues
tRNA: structure
- 75-90 nucleotides, secondary structure, cloverleaf form, anticodon end is opposite 3’ aminoacyl end.
- all tRNAs both EUK & PROK, ahve CCA at 3’ end along with high percentage of chemically modified bases.
- the amino acid is covalently bound to 3’ end of tRNA
- *CCA: Can Carry Amino acids
tRNA: charging
- aminoacyl-tRNA synthetase (1 per amino acid, “matchmaker” uses ATP) scrutinizes amino acid before & after it binds to tRNA.
- if correct, bond is hydrolyzed
- amino acid acid-tRNA bond has energy for formation of peptide bond
- mischarged tRNA reads usual codon but inserts wrong amino acid
- aminoacyl-tRNA synthetase and binding of charged tRNA to codon are repsonsible for accuracy of amino acid selection
- Tetracyclines bind 30S subunit, preventing attachment of aminoacyl-tRNA
tRNA wobble
-accurate base pairing is required only in the first 2 nucleotide positions of an MRNA codon, so codons differing in the 3rd wobble position may code for same tRNA/amino acid (result from degeneracy of genetic code)
Protein synthesis
- Initiation
- Elongation
- Termination
- Initiation
- activated by GTP hydrolysis, initation factors (EUK IFs) help assemble 40S robosomal subunit with initiator tRNA and are released when mRNA and the ribosomal subunit assemble with complex
- Eukaryotes: 40S+60S–> 80S (Even)
- PrOkaryotes: 30S+50S–>70S (Odd)
- ATP-tRNA Activation (charging)
- GTP-tRNA Gripping and Going places (translocation) - Elongation
-aminoacyl-tRNA binds to A site (except for initiator methionine)
-ribosomal rRNA (ribozyme) catalyzes peptide bond formation, transfers growing polypeptide to amino acid in A site
-ribosome advances 3 nucleotides toward 3’ end of mRNA, moving peptidyl tRNA to P site (translocation)
-***think of going APE
A site-incoming Aminoacyl tRNA
P site- accomondates growing Peptide
E site- holds Empty tRNA as it Exits - Termination
- stop codon recognized by release factor and completed protein is released from ribosome.
Protein synthesis:
antibiotics act as protein synthesis inhibitors
- aminoglycosides bind 30S and inhibit formation of initiation complex and cause misreading of mRNA
- tetracyclines bind 30S and block aminoacyl tRNA from entering acceptor site
- Chloramphenicol bind 50S inhibits peptidyl transferase
- macrolides bind 50S and prevent release of uncharged tRNA after it has donated its amino acid
3 post-translational modifications
- trimming-removal of N or C terminal propeptides from zymogens to generate mature proteins
- covalent alterations- phosphorylation, glycosylation, hydroxylation, methylation, acetylation
- proteasomal degradation- attachment of ubiquitin to defective proteins to tag them for breakdown.
Cell cycle phase
checkpoints control transitions between phases of cell cylce
- process regualted by cyclins, CDKs, tumor suppressors.
- mitosis (shortest phase): prophase-metaphase-anaphase-telophase
- G1 G0 are variable duration
Regulation of cell cycle:
- CDKs
- Cyclins
- Cyclin-CDk complexes
- Tumor suppressors
- CDKs- cyclin-dependent kinases; constitutive and inactive
- Cyclins= regulatory proteins that control cell cycle events; phase specific; activate CDKs
- Cyclin-CDk complexes- must be both activated and inactivated for cell cycle to progress
- Tumor suppressors- p53 and hypophosphorylated Rb normally inhibit G1-to-S progression; mutations in these genes result in unrestrained cell division
*** G=gap or growth
S= Synthesis
Cell types: 3
- permanent
- stable (quiescent)
- Labile
- permanent- remain in G0 regenerate from stem cells (neurons, skeletal, cardiac muscle, RBCs
- stable (quiescent)- enter G1 from G0 when stimulated (hepatocytes, lymphocytes)
- Labile- never go into G0, divide rapidly with a short G1 (bone marrow, gut epithelium, skin, hair, hair follicles, germ cells.
Rough Endoplasmic Reticulum
- site for synthesis of secretory (exported) proteins and of N-linked oligosaccharide addition to many proteins
- Nissl bodies (RER in neurons): synthesize enzymes (eg. ChAT [choline acetyletransferase] makes ACh) and peptide neurptransmittors
- free ribosomes- unattached to any membrane; site of synthesis of cytosolic and organellar proteins
- mucus-secreting goblet cells of small intestine and antibody secreting plasma cells are rich in RER
Smooth ER
- site of steroid synthesis and detoxification of drugs and poisons
- liver hepatocytes abd steroid hormone-producing cells of adrenal cortex are rich in SER
Cell trafficking
I-cell disease
Vesicular trafficking proteins
- Golgi distribution center for pro and lipids from ER to vesicles and plasma membrane
- modies N-oligosaccharides on asparagine
- adds O-oligosaccharides on serine and threonine
- adds mannonse-6-phosphate to pro for trafficking to lysosomes
- endosomes are sorting centers for material from outside cell or from Golgi, sending it to lysosomes for destruction or back to membrane/Golgi for further use
I-cell disease (inclusion cell disease):
- inherited lysosomal storage disorder
- failure of addition of mannose-6-phosphate to lysosome proteins (enzymes are secreted outside cell instead of being targeted to lysosome)
- result in coarse facial features, clouded corneas, restricted joint movement, high plasma levels of lysosomal enxymes. fatal during childhood
Vesicular traf pro:
-COPI: Golgi–>golgi (retrograde); Golgi–>ER
-COPII: Golgi–>Golgi (anterograde); ER–>Golgi
Clathrin: trans-Golgi–>lysosomes; plasma membrane–>endosomes (receptor mediated endocytosis)
Peroxisome
membrane-enclosed organelle involved in catabolism of very long fatty acids and amino acids
Proteasome
barrel-shaped protein complex that degrades damaged or unnecessary proteins tagged for destruction with ubiquitin
Microtuble
-cylindrical structure composed of helical array of polymerized dimers of alpha beta tubulin
-each dimer has 2 GTP bound
incorporated into flagella, cilia, mitotic spindles
-grows slowly collapses quickly
-involved in slow axoplasmic transport in neurons
-molecular motor pro: transport cellular cargo toward opposite ends of microtubule tracks
-dynein= retrograde to microtubule (+ to -)
-kinesin=antergrade to microtubule (- to +)
Drugs that act on microtubules
- mebendazole/thiabendazole (antihelminthic)
- griseofulvin (antifungal)
- vincristine/vinblastine (anti-cancer)
- paclitaxel (anti-breast cancer)
- colchicine (anti-gout)
Chediak-Higashi syndrome
- mutation in the lysosomal trafficking regulator gene (LYST)
- whose product is required for microtubule-dependent sorting of endosomal pro into late multivesicular endosomes
- results in recurrent pyogenic infections, partial albinism, peripheral neuropathy
Cilia structure
9+2 arrangment of microtubules
-axonemal dynein-ATPase that links peripheral 9 doublets and causes bending of cilcium by differential sliding of doublets
Kartagener’s syndrome (primary cillary dyskinesia)
- inmotile cilia due to dynein arm defect
- result in male infertility (immotile sperm) and decrease female fertility, bronchiectasis, recurrent sinusitis (bacteria and particles not pushed out); associated with situs inversus.
Cytoskeletal elements:
- actin & myosin
- microtubule
- intermediate filaments
- actin & myosin
- microvilli, muscle contraction, cytokinesis, adherens junctions - microtubule- movement. Cilia, flagella, mitotic spindle, axonal trafficking, centrioles
- intermediate filaments- structure. Vimentin, desmin, cytokeratin, lamins, glial fibrilliary acid proteins (GFAP), neurofilaments
Plasma membrane composition
asymmetric lipid bilayer
contains cholesterol, phospholipids, sphingolipids, glycolipids, proteins
Immunohistochemical stains for intermediate filaments (stain & cell type)
Stain & cell type
- vimentin-connective tissue
- desmin-muscle
- cytokeratin-epithelial cells
- GFAP-NeruroGlia
- neurofilaments-neurons
Sodium-potassium pump
- Na+ K+ ATPase located in plasma membrane with ATP site on cytosolic side
- each ATP consumed, 3 Na+ go out 2 K+ comes in
- during cycle, pump is phosphorylated.
- Ouabain inhibits by binding to K+ site
- cardiac glycosides (digoxin & digitoxin) directly inhibit Na+ K+ ATPase, leading to indirect inhibition of Na+/Ca2+ exchange–> increase Ca2+ phosphorylate which increase cardiac contractility
Collagen Type I-IV
- most abundant pro in human body
- extensively modified by posttranslational modification
- organizes & strengthens extracellular matrix
- *Be (So Totally) Cool, Read Books.
1. most common (90%): Bone, Skin, Tendon, dentin, fascia, cornea, late wound repair. - Type I: bONE–> defective in osteogenesis imperfecta
- Cartilage (include hyaline), virteous body, nucleus pulposus
- Type II: carTWOlage - Reticulin-skin, blood vessels, uterus, fetal tissue, granulation tissue.
- Type III: defective in Ehlers-Danlos (ThreE D) - Basement membrane or basal lamina.
Type IV: under the floor (basement membrane) Defective in Alport syndrome
Collagen synthesis & structure
Inside fibroblasts
- synthesis (RER)
- Hydroxylation (ER)
- Glycosylation (ER)
- Exocytosis
- synthesis (RER)
- translation of collagen alpha chains (pre-procollagen) usually Gly-X-Y (X & Y are proline or lysine) - Hydroxylation (ER)
- of specific proline & lysine residues (requires Vit C; deficiency–>scurvy) - Glycosylation (ER)
- of pro-alpha chain hydroxylysine residues and formation of procollagen via hydrogen and disulfide bonds (triple helix of 3 collagen alpha chains)
- problems forming triple helix–>osteogeneiss imperfecta - Exocytosis
- of procollagen into extracellular space
Collagen synthesis & structure
Outside fibroblasts
- proteolytic processing
- cross linking
- proteolytic processing
- cleavage of disulfide-rich terminal regions of procollagen, transfomring it into insoluble tropocollagen - cross linking
- reinforcement of many staggered tropocollagen molecules by covalent lysine-hydroxylysine cross-linking by Cu2+ containing lysyl oxidase to make collagen fibrils.
- problems with cross-linking–> Ehlers-Danlos
osteogenesis imperfecta
- genetic bone disorder (brittle bone disease) caused by variety of gene defects
- most common form is autosomal dominant with abnormal type I collagen causing:
1. multiple fractures with minimal trauma; may occur during birthing process
2. blue sclerae due to translucency of connective tissue over the choroidal veins
3. hearing loss (abnormal middle ear bones)
4. dental imperfections due to lack of dentin - may be confused with child abuse, 1/10,000 incidence
Ehlers-Danlos syndrome
- faulty collagen synthesis causing hyperextensible skin, tendency to bleed (easy bruising) and hypermobile joints.
- 6 types
- inheritence & severity vary.
- can be autosomal dominant or recessive
- may associated with joint dislocation, berry aneurysms, organ rupture
- Type I or V collagen most frequently affected in severe classic ED syndrome.
Alport syndrome
- due to variety of gene defects resulting in abnormal type IV collagen
- most common form is X-linked recessive
- characterized by progressive hereditary nephritis & deafness
- may associate with ocular disturbances
- Type IV collagen is an important structural component of basement membrane of the kidney, ears, eyes